Evolving Health Expenditure Landscape of the BRICS Nations and Projections to 2025

Abstract

Global health spending share of low/middle income countries continues its long‐term growth. BRICS nations remain to be major drivers of such change since 1990s. Governmental, private and out‐of‐pocket health expenditures were analyzed based on WHO sources. Medium‐term projections of national health spending to 2025 were provided based on macroeconomic budgetary excess growth model. In terms of per capita spending Russia was highest in 2013. India's health expenditure did not match overall economic growth and fell to slightly less than 4% of GDP. Up to 2025 China will achieve highest excess growth rate of 2% and increase its GDP% spent on health care from 5.4% in 2012 to 6.6% in 2025. Russia's spending will remain highest among BRICS in absolute per capita terms reaching net gain from $1523 PPP in 2012 to $2214 PPP in 2025. In spite of BRICS' diversity, all countries were able to significantly increase their investments in health care. The major setback was bold rise in out‐of‐pocket spending. Most of BRICS' growing share of global medical spending was heavily attributable to the overachievement of People's Republic of China. Such trend is highly likely to continue beyond 2025. Copyright © 2016 John Wiley & Sons, Ltd.

Methodological Considerations in Social Cost Studies of Addictive Substances: A Systematic Literature Review

“…This occurred in four studies included in the current review. Nevertheless, even if a uniform methodology was to be developed and used, cross-country comparisons would necessitate sufficient contextualization since countries differ in terms of social security systems, institutional structures, and cultural traditions (36). In 11 of 12 studies included in the review, information on the relative proportion of the different cost items to the total costs was provided.…”

Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature

“…Now they face chronic illnesses, which are far more demanding in terms of social capital and medical resources that need to be devoted (88). Among the few bright success stories in lessening the grip of major NCDs are certainly the BRICS nations (89). Such change of morbidity has clearly reflected on the demand for pharmaceuticals and national spending on medicines in a large number of countries (90, 91).…”

Unnecessary Hysterectomy due to Menorrhagia and Disorders of Hemostasis: An Example of Overuse and Excessive Demand for Medical Services

“…Associated workload and economic burden of abnormal uterine bleeding was proved to be significant even in highly effective health sectors. The national health expenditure available and current resource allocation strategy varies greatly with mature Western (Jakovljevic, 2016) and top performing health markets representing different historical legacies (Jakovljevic et al, 2016a). However, regardless of these large geographical diversity, willingness to pay threshold in bleeding disorders remains an issue for public debate in many countries (Eastaugh, 2000).…”